For the first time, patients undergoing percutaneous coronary intervention (PCI) can benefit from formal recommendations regarding the management of risks and complications associated with the procedure. Members of the American Heart Association (AHA) Diagnostic and Interventional Catheterization Committee and Council on Clinical Cardiology recently issued a new set of guidelines to provide clinicians with a review of the complications that can occur during PCI. "Management of Patients Undergoing Percutaneous Coronary Revascularization" was published in the July 15 issue of the Annals of Internal Medicine. It is available online at http://www.annals.org.
Targeted Drug Combination Reveals New Activity in Brain Tumors
December 28th 2021A combination of two targeted cancer drugs showed unprecedented, “clinically meaningful” activity in patients with highly malignant brain tumors that carried a rare genetic mutation, according to a clinical trial report by investigators from Dana-Farber Cancer Institute.